Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005707 |
---|---|
Receipt number | R000006733 |
Scientific Title | Phase II study of R-CHOP and R-high-dose MTX therapy for untreated intravascular large B-cell lymphoma (PRIMEUR-IVL) |
Date of disclosure of the study information | 2011/06/03 |
Last modified on | 2020/06/07 14:47:50 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/06/02 17:02:51 | ||
2 | Update | 2011/08/19 11:40:18 | Recruitment status Last follow-up date |
|
3 | Update | 2013/12/06 09:40:39 | Email Last name of contact person Last name of contact person TEL Name of person sending information Name of person sending information Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2014/07/16 16:44:01 | Last follow-up date |
|
5 | Update | 2015/01/27 09:13:38 | Interventions/Control_1 |
|
6 | Update | 2015/12/10 09:26:58 | Email |
|
7 | Update | 2017/01/16 10:05:36 | UMIN ID1 |
|
8 | Update | 2017/01/16 10:11:24 | Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Organization |
|
9 | Update | 2017/06/05 13:13:42 | Recruitment status |
|
10 | Update | 2018/07/02 23:53:58 | Narrative objectives1 Narrative objectives1 |
|
11 | Update | 2018/07/02 23:56:44 | Interventions/Control_1 Interventions/Control_1 |
|
12 | Update | 2018/07/03 00:00:35 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Address Address TEL Organization1 Address1 Tel1 Email1 Institutions |
|
13 | Update | 2019/04/13 11:27:16 | UMIN ID2 |
|
14 | Update | 2019/04/13 11:36:13 | Public title Public title Scientific Title Scientific Title |
|
15 | Update | 2019/04/13 11:53:42 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Zip code Address Last name of contact person Last name of contact person Zip code Address Homepage URL Organization Organization Organization Category of Funding Organization Organization1 Tel1 Email1 Organization Organization Address Address Tel Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Institutions |
|
16 | Update | 2019/04/13 11:55:28 | URL releasing protocol Number of participants that the trial has enrolled |
|
17 | Update | 2019/04/13 12:08:30 | Date of IRB Anticipated trial start date Last follow-up date |
|
18 | Update | 2020/06/07 14:41:51 | Recruitment status |
|
19 | Update | 2020/06/07 14:42:48 | Publication of results URL related to results and publications Results Results Results date posted Date of the first journal publication of results Adverse events Adverse events Outcome measures Outcome measures |
|
20 | Update | 2020/06/07 14:47:50 | Publication of results |